23948sdkhjf
Logga in eller skapa en prenumeration för att spara artiklar
Få tillgång till allt innehåll på Life Science Sweden
Ingen bindningstid eller kortinformation krävs
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
Annons
Annons

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.
Annons

The European Patent Office, EPO, declared last week that a patent in mRNA technology, owned by Moderna, is invalid. This is reported by Reuters.

Moderna has sued Biontech in Germany and other countries, claiming that the company has copied mRNA technology that Moderna had patented long before covid-19 appeared in 2019.

Annons

Moderna has announced that it intends to appeal the decision.

Annons
Annons
Annons
Annons
News in English Se tema
Annons Annons
BREAKING
{{ article.headline }}
0.112|instance-web03